Discover open access scientific publications

Search, annotate, share and cite publications

Publications by William S. Pomat

Pneumococcal Responses Are Similar in Papua New Guinean Children Aged 3-5 Years Vaccinated in Infancy With Pneumococcal Polysaccharide Vaccine With or Without Prior Pneumococcal Conjugate Vaccine, or Without Pneumococcal Vaccination

PLoS ONE

Multidisciplinary

2017

English

Related publications

Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis

English

Pneumococcal Vaccine.

Postgraduate Medical Journal

Medicine

1997

English

Serotype-Specific Immune Unresponsiveness to Pneumococcal Conjugate Vaccine Following Invasive Pneumococcal Disease

Infection and Immunity

English

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

MMWR. Morbidity and mortality weekly report

Health Information Management

English

Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in an Isolated Pneumococcal Vaccine-Naïve Indigenous Population

European Respiratory Journal

English

Use of the New Pneumococcal Conjugate Vaccine in the USA

Archives of Disease in Childhood

English

Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children

Journal of Immunology Research

English

Spatial Variability in the Persistence of Pneumococcal Conjugate Vaccine-Targeted Pneumococcal Serotypes Among Adults

Epidemiology

2017

English

Recommendations for the Prevention of Streptococcus Pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by William S. Pomat

Pneumococcal Responses Are Similar in Papua New Guinean Children Aged 3-5 Years Vaccinated in Infancy With Pneumococcal Polysaccharide Vaccine With or Without Prior Pneumococcal Conjugate Vaccine, or Without Pneumococcal Vaccination

Related publications

Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis

Pneumococcal Vaccine.

Serotype-Specific Immune Unresponsiveness to Pneumococcal Conjugate Vaccine Following Invasive Pneumococcal Disease

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in an Isolated Pneumococcal Vaccine-Naïve Indigenous Population

Use of the New Pneumococcal Conjugate Vaccine in the USA

Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children

Spatial Variability in the Persistence of Pneumococcal Conjugate Vaccine-Targeted Pneumococcal Serotypes Among Adults

Recommendations for the Prevention of Streptococcus Pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)